01.04.2020
COVID-19 stimulates innovations in open science and publishing
« Undoubtedly, the coronavirus (COVID-19) pandemic will have a significant ongoing impact on the medical sector. Challenges for conducting clinical trials are recognised in recently released FDA guidance, with journals also highlighting the lasting effect that the pandemic will have on medical research. A JAMA viewpoint article, co-authored by the Deputy Editor, urges efforts to maintain clinical trial integrity and notes that future publications should acknowledge the methodological changes necessary to sustain clinical trials during the pandemic. (…) »
